Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Horizons in Cancer Research. Volume 72, PDF eBook

Horizons in Cancer Research. Volume 72 PDF

Edited by Hiroto S. Watanabe

Part of the Horizons in Cancer Research series

PDF

Please note: eBooks can only be purchased with a UK issued credit card and all our eBooks (ePub and PDF) are DRM protected.

Description

The first chapter of Horizons in Cancer Research. Volume 72 discusses the Ewing's sarcoma family of tumors, including classic Ewing's sarcoma of the bone, extraskeletal Ewing's sarcoma and malignant peripheral primitive neuroectodermal tumor of both bone and soft tissue.

The following chapter discusses Primary Ewing's sarcoma of the base of the tongue, particularly its diagnosis and treatment.

Additionally, the authors examine dual proteasome and histone deacetylase6 inhibitor, dual MDM2 and histone deacetylase inhibitor, and dual bromodomain-containing protein 4 and histone deacetylase inhibitor.

The authors go on to examine the genes and proteins involved in mitosis that are proposed as candidates for biomarkers in different types of cancer (colon, lung, prostate, breast and ovarian, among others).

The penultimate chapter reviews the published evidence of aromatase inhibitors in breast cancer risk reduction. The recommended patient populations for the use of aromatase inhibitors, expected benefits, adverse effects and monitoring parameters are addressed.

The transcription factor and chromatin structure-related aspects of cancer treatment are the focus of the final chapter.

Information

Information